Bosh sahifa007570 ā¢ KRX
add
Ilyang Pharmaceutical Co., Ltd
Yopilish kursi
13Ā 230,00Ā ā©
Kunlik diapazon
12Ā 960,00Ā ā© - 13Ā 430,00Ā ā©
Yillik diapazon
12Ā 300,00Ā ā© - 16Ā 250,00Ā ā©
Bozor kapitalizatsiyasi
253,80Ā mlrd KRW
OŹ»rtacha hajm
25,50Ā ming
Narx/foyda
416,54
Dividend daromadliligi
1,15%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 82,70Ā mlrd | -3,11% |
Joriy xarajat | 42,20Ā mlrd | -11,06% |
Sof foyda | 1,09Ā mlrd | 137,27% |
Sof foyda marjasi | 1,31 | 138,42% |
Har bir ulushga tushum | ā | ā |
EBITDA | 5,61Ā mlrd | -9,79% |
Amaldagi soliq stavkasi | 21,45% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 24,62Ā mlrd | 66,57% |
Jami aktivlari | 496,67Ā mlrd | 7,71% |
Jami passivlari | 228,31Ā mlrd | 16,61% |
Umumiy kapital | 268,36Ā mlrd | ā |
Tarqatilgan aksiyalar | 17,97Ā mln | ā |
Narxi/balansdagi bahosi | 1,04 | ā |
Aktivlardan daromad | 1,38% | ā |
Kapitaldan daromad | 1,86% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 1,09Ā mlrd | 137,27% |
Operatsiyalardan naqd pul | 6,86Ā mlrd | 194,27% |
Sarmoyadan naqd pul | -12,01Ā mlrd | -758,15% |
Moliyadan naqd pul | 2,76Ā mlrd | 727,52% |
Naqd pulning sof oŹ»zgarishi | -2,05Ā mlrd | -322,49% |
BoŹ»sh pul | -3,66Ā mlrd | -29,52% |
Haqida
Tashkil etilgan
1946
Sayt
Xodimlar soni
651
